U.S. Markets open in 2 hrs 37 mins
S&P Futures
2,470.00
-1.25 (-0.05%)Dow Futures
21,551.00
-30.00 (-0.14%)
| Previous Close | 0.604 |
| Open | 0.610 |
| Bid | 0.561 x 100 |
| Ask | 0.716 x 1000 |
| Day's Range | 0.610 - 0.644 |
| 52 Week Range | 0.360 - 0.990 |
| Volume | 2,776,434 |
| Avg. Volume | 8,844,395 |
| Market Cap | 95.03M |
| Beta | 1.67 |
| PE Ratio (TTM) | -1.18 |
| EPS (TTM) | -0.53 |
| Earnings Date | Jul 27, 2017 - Jul 31, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.00 |
- Investopedia•21 days ago
Penny Stocks to Watch for June 2017 (CYTR, DELT)
These ten penny stocks trading on U.S. public exchanges could gain substantial ground in 2017.
- PR Newswire•last month
CytRx Announces Reshaping of Clinical and Regulatory Executive Team
LOS ANGELES, June 13, 2017 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that Shanta Chawla, M.D., who ...
- Accesswire•last month
Today's Research Reports on Stocks to Watch: CytRx and Hydrogenics Corporation
NEW YORK, NY / ACCESSWIRE / June 9, 2017 / CytRx's shares saw a big gaining day yesterday after the company announced a big regulatory pathway update about aldoxorubicin, a tumor-targeted doxorubicin conjugate ...
